Lars Jørgen Østergaard

Societal costs due to meningococcal disease: a national registry-based study

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Societal costs due to meningococcal disease : a national registry-based study. / Gustafsson, Nina; Stallknecht, Sandra Elkjær; Skovdal, Mette; Poulsen, Peter Bo; Østergaard, Lars.

In: ClinicoEconomics and Outcome Research, Vol. 10, 2018, p. 563-572.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Gustafsson, N, Stallknecht, SE, Skovdal, M, Poulsen, PB & Østergaard, L 2018, 'Societal costs due to meningococcal disease: a national registry-based study', ClinicoEconomics and Outcome Research, vol. 10, pp. 563-572. https://doi.org/10.2147/CEOR.S175835

APA

Gustafsson, N., Stallknecht, S. E., Skovdal, M., Poulsen, P. B., & Østergaard, L. (2018). Societal costs due to meningococcal disease: a national registry-based study. ClinicoEconomics and Outcome Research, 10, 563-572. https://doi.org/10.2147/CEOR.S175835

CBE

Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L. 2018. Societal costs due to meningococcal disease: a national registry-based study. ClinicoEconomics and Outcome Research. 10:563-572. https://doi.org/10.2147/CEOR.S175835

MLA

Gustafsson, Nina et al. "Societal costs due to meningococcal disease: a national registry-based study". ClinicoEconomics and Outcome Research. 2018, 10. 563-572. https://doi.org/10.2147/CEOR.S175835

Vancouver

Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L. Societal costs due to meningococcal disease: a national registry-based study. ClinicoEconomics and Outcome Research. 2018;10:563-572. https://doi.org/10.2147/CEOR.S175835

Author

Gustafsson, Nina ; Stallknecht, Sandra Elkjær ; Skovdal, Mette ; Poulsen, Peter Bo ; Østergaard, Lars. / Societal costs due to meningococcal disease : a national registry-based study. In: ClinicoEconomics and Outcome Research. 2018 ; Vol. 10. pp. 563-572.

Bibtex

@article{5a2cc13be1524a3e82ef051873467f99,
title = "Societal costs due to meningococcal disease: a national registry-based study",
abstract = "Purpose: Limited detailed evidence exists on the societal costs of meningococcal disease. The objective of this study was to estimate the average 5-year societal cost of events attributable to meningococcal disease in Denmark.Methods: The study was based on the nationwide Danish registries. Incident patients diagnosed with meningococcal disease were identified and each matched with two controls, using direct matching on age, gender, and level of education. Siblings constituted a secondary control population where one patient was matched with one sibling control without meningococcal disease. Costs related to health care in the primary and secondary sectors, prescription medicine, municipality home care services and costs of production loss, ie, estimated loss of yearly earnings, were included (1997-2015).Results: The incidence of meningococcal disease fluctuated between 1980 and 2015. The average attributable societal costs were highest the first year after diagnosis, with costs equaling USD 18,920 per event in the primary study population (matched controls) and USD 16,169 in the secondary study population (sibling controls). Hospital admission costs accounted for 65% and production loss for 30%; however, having a lifetime perspective and including loss due to premature death further increase the costs of meningococcal disease events.Conclusion: The costs of meningococcal disease are substantial, and the estimated costs of event may be informative in evaluating the impact of preventive interventions targeting meningococcal disease.",
author = "Nina Gustafsson and Stallknecht, {Sandra Elkj{\ae}r} and Mette Skovdal and Poulsen, {Peter Bo} and Lars {\O}stergaard",
year = "2018",
doi = "10.2147/CEOR.S175835",
language = "English",
volume = "10",
pages = "563--572",
journal = "ClinicoEconomics and Outcome Research",
issn = "1178-6981",
publisher = "Dove Medical Press Ltd.(Dovepress)",

}

RIS

TY - JOUR

T1 - Societal costs due to meningococcal disease

T2 - a national registry-based study

AU - Gustafsson, Nina

AU - Stallknecht, Sandra Elkjær

AU - Skovdal, Mette

AU - Poulsen, Peter Bo

AU - Østergaard, Lars

PY - 2018

Y1 - 2018

N2 - Purpose: Limited detailed evidence exists on the societal costs of meningococcal disease. The objective of this study was to estimate the average 5-year societal cost of events attributable to meningococcal disease in Denmark.Methods: The study was based on the nationwide Danish registries. Incident patients diagnosed with meningococcal disease were identified and each matched with two controls, using direct matching on age, gender, and level of education. Siblings constituted a secondary control population where one patient was matched with one sibling control without meningococcal disease. Costs related to health care in the primary and secondary sectors, prescription medicine, municipality home care services and costs of production loss, ie, estimated loss of yearly earnings, were included (1997-2015).Results: The incidence of meningococcal disease fluctuated between 1980 and 2015. The average attributable societal costs were highest the first year after diagnosis, with costs equaling USD 18,920 per event in the primary study population (matched controls) and USD 16,169 in the secondary study population (sibling controls). Hospital admission costs accounted for 65% and production loss for 30%; however, having a lifetime perspective and including loss due to premature death further increase the costs of meningococcal disease events.Conclusion: The costs of meningococcal disease are substantial, and the estimated costs of event may be informative in evaluating the impact of preventive interventions targeting meningococcal disease.

AB - Purpose: Limited detailed evidence exists on the societal costs of meningococcal disease. The objective of this study was to estimate the average 5-year societal cost of events attributable to meningococcal disease in Denmark.Methods: The study was based on the nationwide Danish registries. Incident patients diagnosed with meningococcal disease were identified and each matched with two controls, using direct matching on age, gender, and level of education. Siblings constituted a secondary control population where one patient was matched with one sibling control without meningococcal disease. Costs related to health care in the primary and secondary sectors, prescription medicine, municipality home care services and costs of production loss, ie, estimated loss of yearly earnings, were included (1997-2015).Results: The incidence of meningococcal disease fluctuated between 1980 and 2015. The average attributable societal costs were highest the first year after diagnosis, with costs equaling USD 18,920 per event in the primary study population (matched controls) and USD 16,169 in the secondary study population (sibling controls). Hospital admission costs accounted for 65% and production loss for 30%; however, having a lifetime perspective and including loss due to premature death further increase the costs of meningococcal disease events.Conclusion: The costs of meningococcal disease are substantial, and the estimated costs of event may be informative in evaluating the impact of preventive interventions targeting meningococcal disease.

U2 - 10.2147/CEOR.S175835

DO - 10.2147/CEOR.S175835

M3 - Journal article

C2 - 30323634

VL - 10

SP - 563

EP - 572

JO - ClinicoEconomics and Outcome Research

JF - ClinicoEconomics and Outcome Research

SN - 1178-6981

ER -